KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nektar Therapeutics (NKTR) Raw Materials: 2010-2023

Historic Raw Materials for Nektar Therapeutics (NKTR) over the last 11 years, with Dec 2023 value amounting to $1.9 million.

  • Nektar Therapeutics' Raw Materials was N/A to $1.7 million in Q2 2024 from the same period last year, while for Jun 2024 it was $1.7 million, marking a year-over-year change of. This contributed to the annual value of $1.9 million for FY2023, which is 27.73% down from last year.
  • Per Nektar Therapeutics' latest filing, its Raw Materials stood at $1.9 million for FY2023, which was down 27.73% from $2.6 million recorded in FY2022.
  • Nektar Therapeutics' 5-year Raw Materials high stood at $2.6 million for FY2022, and its period low was $1.9 million during FY2023.
  • For the 2-year period, Nektar Therapeutics' Raw Materials averaged around $2.2 million, with its median value being $2.2 million (2022).
  • Data for Nektar Therapeutics' Raw Materials shows a maximum YoY declined of 27.73% (in 2023) over the last 5 years.
  • Nektar Therapeutics' Raw Materials (Yearly) stood at $2.6 million in 2022, then declined by 27.73% to $1.9 million in 2023.